Skip to main navigation Skip to search Skip to main content

Quantification of the smoking-associated cancer risk with rate advancement periods: Meta-analysis of individual participant data from cohorts of the CHANCES consortium

  • on behalf of the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES)
  • Heidelberg University 
  • German Cancer Research Center
  • International Agency for Research on Cancer
  • National Institute of Public Health and the Environment
  • Utrecht University
  • Imperial College London
  • University of Malaya
  • Queen's University Belfast
  • Erasmus University Rotterdam
  • Umeå University
  • National Institute for Health and Welfare
  • National Institutes of Health
  • University of Tromsø – The Arctic University of Norway
  • Wageningen University & Research
  • Karolinska Institutet
  • Danish Cancer Society
  • Jagiellonian University Medical College
  • Institute of Internal and Preventive Medicine
  • Czech National Institute of Public Health
  • Lithuanian University of Health Sciences
  • University College London
  • Helenic Health Foundation
  • National and Kapodistrian University of Athens

Research output: Contribution to journalArticlepeer-review

148 Scopus citations

Abstract

Background: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance communication of smoking related risk to the general population. Thus, we estimated RAPs for the association of smoking exposure (smoking status, time since smoking cessation, smoking intensity, and duration) with total and site-specific (lung, breast, colorectal, prostate, gastric, head and neck, and pancreatic) cancer incidence and mortality. Methods: This is a meta-analysis of 19 population-based prospective cohort studies with individual participant data for 897,021 European and American adults. For each cohort we calculated hazard ratios (HRs) for the association of smoking exposure with cancer outcomes using Cox regression adjusted for a common set of the most important potential confounding variables. RAPs (in years) were calculated as the ratio of the logarithms of the HRs for a given smoking exposure variable and age. Meta-analyses were employed to summarize cohort-specific HRs and RAPs. Results: Overall, 140,205 subjects had a first incident cancer, and 53,164 died from cancer, during an average follow-up of 12 years. Current smoking advanced the overall risk of developing and dying from cancer by eight and ten years, respectively, compared with never smokers. The greatest advancements in cancer risk and mortality were seen for lung cancer and the least for breast cancer. Smoking cessation was statistically significantly associated with delays in the risk of cancer development and mortality compared with continued smoking. Conclusions: This investigation shows that smoking, even among older adults, considerably advances, and cessation delays, the risk of developing and dying from cancer. These findings may be helpful in more effectively communicating the harmful effects of smoking and the beneficial effect of smoking cessation.

Original languageEnglish
Article number62
JournalBMC Medicine
Volume14
Issue number1
DOIs
StatePublished - Apr 5 2016

Keywords

  • Cancer
  • Cohort
  • Incidence
  • Meta-analysis
  • Mortality
  • Smoking

Fingerprint

Dive into the research topics of 'Quantification of the smoking-associated cancer risk with rate advancement periods: Meta-analysis of individual participant data from cohorts of the CHANCES consortium'. Together they form a unique fingerprint.

Cite this